Guided Therapeutics (GTHP) Inventory Average (2012 - 2025)
Guided Therapeutics' (GTHP) quarterly Inventory Average came in at $515500.0 in Q4 2025, down 18.75% year-on-year from $634500.0 in Q4 2024, and down 12.48% quarter-over-quarter from $589000.0 in Q3 2025.
Guided Therapeutics (GTHP) Inventory Average (2012 - 2025) Analysis & Trends
Guided Therapeutics has disclosed Inventory Average across 14 years of filings, most recently posting $515500.0 for Q4 2025.
- Inventory Average for Q4 2025 came in at $515500.0, down 18.75% year-over-year; the trailing twelve-month figure through Dec 2025 was $515500.0 (down 18.75% YoY), and the FY2025 annual result was $540500.0, down 14.55% from the prior year.
- Inventory Average came in at $515500.0 for Q4 2025 at Guided Therapeutics, down from $589000.0 in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $640000.0 in Q4 2023 to a low of $515500.0 in Q4 2025.
- The 5-year median for Inventory Average is $608000.0 (2021), against an average of $599475.0.
- Across the five-year window, Inventory Average surged 1074.04% in 2021 and slipped 18.75% in 2025, its largest moves.
- Guided Therapeutics' Inventory Average stood at $580500.0 in 2021, then retreated by 1.46% to $572000.0 in 2022, then rose by 11.89% to $640000.0 in 2023, then declined by 0.86% to $634500.0 in 2024, then retreated by 18.75% to $515500.0 in 2025.
- The last three Inventory Average figures came in at $515500.0 (Q4 2025), $589000.0 (Q3 2025), and $614000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 6.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 5.36 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 6.23 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 3.03 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 1.12 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.49 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 661.35 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 652.65 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 515,500.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 515,500.00 |
| Sep 30, 2025 | 589,000.00 |
| Jun 30, 2025 | 614,000.00 |
| Mar 31, 2025 | 633,000.00 |
| Dec 31, 2024 | 634,500.00 |
| Sep 30, 2024 | 634,000.00 |
| Jun 30, 2024 | 632,000.00 |
| Mar 31, 2024 | 632,000.00 |
| Dec 31, 2023 | 640,000.00 |
| Sep 30, 2023 | 610,500.00 |
| Jun 30, 2023 | 579,000.00 |
| Mar 31, 2023 | 566,500.00 |
| Dec 31, 2022 | 572,000.00 |
| Sep 30, 2022 | 582,500.00 |
| Jun 30, 2022 | 569,500.00 |
| Mar 31, 2022 | 570,500.00 |
| Dec 31, 2021 | 580,500.00 |
| Sep 30, 2021 | 610,500.00 |
| Jun 30, 2021 | 618,500.00 |
| Mar 31, 2021 | 605,500.00 |